CRP Sante, now known as Luxembourg Institute of Health, is a public biomedical research organization and a venture capital firm that invests in the development of new diagnostics. Founded 1988 in Strassen, Luxembourg, it typically invests in early stage ventures. On Jun 10, 2010, the company invested in Complix, a biopharmaceutical company in Belgium developing Alphabodies, a novel class of biopharmaceuticals. The company invested $6.2M in its Series A round.
The firm focuses on the development of new diagnostics, preventive strategies, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens.
Ulf Nehrbass, PhD
Chief Executive Officer
Deputy Medical and Technical Director
Laetitia Huiart, MD, PhD
Director of the Department of Population Health
Chief Financial and Administrative Officer
Markus Ollert, MD
Director of the Department of Infection & Immunity
Simone Niclou, PhD
Director of the Department of Oncology
Head of Unit HIV / AIDS
Documentaries, videos and podcasts